London Healthcare Week: After announcing FIH data from its oral GLP in obesity in September, Terns is also getting ready to release initial data in December for its allosteric BCR ABL cancer program
CEO Amy Burroughs walks us through what the company saw in the obesity program, and previews what to expect from initial cohorts in CML next month